US Stock MarketDetailed Quotes

EHC Encompass Health

Watchlist
  • 94.740
  • +0.330+0.35%
Close Jan 17 16:00 ET
  • 94.710
  • -0.030-0.03%
Pre 06:57 ET
9.55BMarket Cap22.94P/E (TTM)

Encompass Health Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Encompass Health Q4 2024 Estimates Date

Currency：USDFeb 6, 2025

Estimate YoY
Revenue
1.38B
+10.78%
EPS
1.01
+17.44%
Analyst Rating
Strong Buy

Dec 31, 2024

Encompass Health Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 10 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 1.435B--
Feb 6, 20252024/Q4-- / 1.381B--
Oct 28, 20242024/Q31.351B / 1.331B--
Aug 5, 20242024/Q21.301B / 1.305B--
Apr 24, 20242024/Q11.316B / 1.273B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 1.435B--
Feb 6, 20252024/Q4-- / 1.381B--
Oct 28, 20242024/Q31.351B / 1.331B--
Aug 5, 20242024/Q21.301B / 1.305B--
Apr 24, 20242024/Q11.316B / 1.273B--

Unlock Free Earnings Estimates

Encompass Health Earnings Reports

  • Encompass Health | 10-Q: Q3 2024 Earnings Report

    Nov 1, 2024 14:48 ET

  • Encompass Health | 8-K: Encompass Health reports results for third quarter 2024 Increases full-year guidance

    Oct 28, 2024 16:34 ET

  • Encompass Health | 10-Q: Q2 2024 Earnings Report

    Aug 6, 2024 16:40 ET

  • Encompass Health | 8-K: Encompass Health reports results for second quarter 2024 Increases full-year guidance

    Aug 5, 2024 17:03 ET

    • Read more

    Trending Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    Hutchmed (China)
    HCM
    +6.61%
    Ermenegildo Zegna NV
    ZGN
    +2.34%
    New Fortress Energy
    NFE
    +2.32%
    Enerpac Tool
    EPAC
    +1.91%
    eBay
    EBAY
    +1.74%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Dec 31, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data